Tylenol

ApprovedSmall molecule

MMetroHealth Medical Center

Tylenol is one of 93 small molecule programs targeting Total Knee Arthroplasty. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Total Knee ArthroplastyActive, not recruiting

HysterectomyActive, not recruiting

StrabismusActive, not recruiting

Prostate CancerActive, not recruiting

Total Knee ArthroplastyPreclinical

Active, not recruiting

HysterectomyApproved

Active, not recruiting

StrabismusPhase 2

Active, not recruiting

Prostate CancerPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

1399 competitors in Prostate Cancer

#DrugCompanyPhaseTrials

Tylenol

MMetroHealth Medical Center

Approved

1 2

Novantrone

Pfizer

Preclinical

5 3

Mekinist

Novartis

Preclinical

3 4

Trexall

Alnylam Pharmaceuticals

Preclinical

—5

Jatenzo

GGrupo Espanol de Tumores Neuroendocrinos

Preclinical

2 6

Viagra

VViatris Specialty LLC

Preclinical

1 7

Duragesic

CCephalon

Preclinical

1 8

Ranexa

MMenarini International Operations Luxembourg SA

Preclinical

1 9

Prednisone/prednisolone

Roche

Preclinical

3 10

Triptorelin Pamoate

Ipsen

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 2Recruiting

Pain Management

NCT06505187

Q4 2028

Phase 2Not yet recruiting

Strabismus

NCT06689943

Clinical

Trials by Indication[1]

Multimodal Analgesia2 trials

Multimodal Analgesia Effect on Post Surgical Patient

Active, not recruiting·UUniversity of California, Davis·Phase 4·NCT04240626·60 enrolled

Multimodal Analgesia Versus Traditional Opiate Based Analgesia

Unknown status·SShanghai Zhongshan Hospital·N/A·NCT03521167·225 enrolled

Pain Management1 trial

Celecoxib for ENT Pain Management

Recruiting·UUniversity of Wisconsin, Madison·Phase 2·NCT06505187·84 enrolled

Prostate Cancer1 trial

PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer

Completed·NNational Cancer Institute (NCI)·Phase 1/2·NCT02933255·24 enrolled

Obese Adolescents1 trial

Acetaminophen Dosing in Obese Adolescents

Suspended·—·Phase 3·NCT03192566·6 enrolled

Oocyte Retrieval1 trial

Rectal Acetaminophen During Oocyte Retrievals

Unknown status·UUniversity of South Florida·N/A·NCT05990868·78 enrolled

6 more indications

Tonsillectomy1 trial

Post-tonsillectomy Pain Control in Adults

Terminated·UUniversity of Nebraska·Phase 4·NCT02358850·27 enrolled

Strabismus1 trial

Pain After Strabismus Surgery

Not yet recruiting·—·Phase 2·NCT06689943·80 enrolled

Hysterectomy1 trial

ICE-T Pain Regimen for Total Laparoscopic Hysterectomy

Completed·MMetroHealth Medical Center·Phase 4·NCT03987022·66 enrolled

Lumbar Fusion Surgery1 trial

Clinical Effect of Preventive Use of Tylenol on Fever After Removal of Drainage Tube in Lumbar Fusion Surgery

Completed·PPeking University Third Hospital·N/A·NCT04042948·183 enrolled

Total Knee Arthroplasty1 trial

The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

Completed·RRothman Institute Orthopaedics·N/A·NCT04003350·216 enrolled

Head and Neck Cancer1 trial

Multimodal Management for Perioperative Analgesia in Otolaryngology - Head and Neck Free Flap Reconstructive Surgery: A Prospective Study

Completed·UUniversity of Kansas Medical Center·Approved·NCT04246697·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 12 trial records for Tylenol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tylenol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tylenol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — MetroHealth Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: MMetroHealth Medical Center

Tylenol

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Q4 2028

Trials by Indication[1]

Multimodal Analgesia2 trials

Pain Management1 trial

Prostate Cancer1 trial

Obese Adolescents1 trial

Oocyte Retrieval1 trial

Tonsillectomy1 trial

Strabismus1 trial

Hysterectomy1 trial

Lumbar Fusion Surgery1 trial

Total Knee Arthroplasty1 trial

Head and Neck Cancer1 trial

References

Drug Info

Quick Facts

Related News